The conventional wisdom is that it takes far longer for many potentially beneficial innovations to be widely adopted in health care than in other industries, especially consumer markets. An oft-cited example is the iPhone — more than 700 million have been sold since the first model went on sale eight years ago. By comparison it can take 10 to 20 years for a new health care practice to go from development to widespread adoption, according to some estimates.
Read MoreMedTech Boston features Bloodbuy→
/
The Forum on Healthcare Innovation, a collaboration between Harvard Business School (HBS) and the Harvard Medical School (HMS), recently announced the finalists of their Harvard Health Acceleration Challenge: Bloodbuy, I-Pass, Medalogix and Twine.
Read MoreSTBTC and the Harvard Forum on Healthcare Innovation
/
Dallas, Texas-based healthcare technology startup Bloodbuy is using South Texas Blood & Tissue Center (STBTC) to pilot its technology in connection with Harvard Forum on Healthcare Innovation. Once again taking the lead in cutting-edge medical research, STBTC and BioBridge Global will figure prominently in a Harvard Business School case study that will be presented by the Harvard Business School and Harvard Medical School's at the Forum on Healthcare Innovation conference in April.
Read MoreHarvard Forum on Healthcare Innovation→
/
The Forum on Health Care Innovation, a collaboration between Harvard Business School (HBS) and Harvard Medical School (HMS), announced today the four finalists in its Health Acceleration Challenge, which focuses on taking compelling, already-implemented health care solutions and helping them to grow and increase their impact through powerful networking and funding opportunities.
Read MoreBoston Globe features Bloodbuy→
/
A third finalist is Bloodbuy, a Dallas company that designed a price-matching system, similar to Priceline, to link hospitals with blood banks. The cost and supply of donor blood varies with geography and season. Bloodbuy allows hospitals to choose a location and set pricing for the supply they need, then matches them with blood centers that qualify.
Read More